Explore the Trump administration's federal medical cannabis reclassification, moving it from a highly controlled category and offering significant tax rel…
A recent advisory from Maine's Office of Cannabis Policy highlights unsafe levels of mold and pesticides in medical cannabis products, prompting a recall.…
The West Virginia Supreme Court is reviewing if medical cannabis odor alone provides probable cause for home searches, impacting legal interpretations for…
Medical cannabis program enrollment is expected to surge after Schedule III rescheduling. Learn how tax relief, insurance pathways, and physician engageme…
Explore how U.S. Congressional actions are impacting industrial hemp businesses and the proposed marijuana rescheduling, creating market uncertainty for o…
Explore the US Justice Department's reclassification of medical cannabis to Schedule III, impacting tax breaks for businesses and easing research restrict…
HempToday's Kehrt Reyher discusses industrial hemp policy, CBD regulation, and market development. Insights cover legislative efforts, construction applic…
A Travis County district judge has extended a temporary injunction, allowing Texas shops to continue selling smokable hemp products until July 27. Learn h…
The U.S. House passed the Farm Bill, leaving federal rules for hemp-derived cannabinoids unchanged. Learn how this impacts the multi-billion-dollar indust…
A new poll reveals 75% of Texas voters support medical cannabis reforms, despite low awareness of the state's Compassionate Use Program. Learn about recen…